Veru (NASDAQ:VERU) Share Price Passes Above Two Hundred Day Moving Average of $0.78

Veru Inc. (NASDAQ:VERU)’s share price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.78 and traded as high as $1.42. Veru shares last traded at $1.35, with a volume of 3,708,203 shares traded.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on VERU shares. HC Wainwright reiterated a “buy” rating and set a $2.00 price target on shares of Veru in a report on Thursday, February 8th. Oppenheimer restated an “outperform” rating and set a $5.00 price objective (down previously from $7.00) on shares of Veru in a report on Monday, April 15th. Finally, Raymond James initiated coverage on Veru in a report on Thursday, March 28th. They set an “outperform” rating and a $3.00 price objective for the company.

Veru Stock Up 8.0 %

The company has a market cap of $197.61 million, a P/E ratio of -1.80 and a beta of -0.22. The business has a fifty day moving average price of $0.87 and a 200-day moving average price of $0.78.

Veru (NASDAQ:VERU) last released its quarterly earnings results on Monday, April 1st. The company reported ($0.09) earnings per share for the quarter. Veru had a negative net margin of 405.04% and a negative return on equity of 257.92%. The business had revenue of $2.14 million during the quarter. As a group, research analysts expect that Veru Inc. will post -0.26 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in VERU. Perceptive Advisors LLC raised its position in Veru by 412.4% during the fourth quarter. Perceptive Advisors LLC now owns 5,584,699 shares of the company’s stock valued at $4,021,000 after purchasing an additional 4,494,821 shares in the last quarter. Octagon Capital Advisors LP acquired a new position in Veru during the fourth quarter valued at approximately $2,736,000. AIGH Capital Management LLC acquired a new position in Veru during the fourth quarter valued at approximately $2,476,000. Worth Venture Partners LLC acquired a new position in Veru during the fourth quarter valued at approximately $616,000. Finally, ADAR1 Capital Management LLC acquired a new position in shares of Veru during the fourth quarter worth $360,000. 47.16% of the stock is currently owned by institutional investors and hedge funds.

Veru Company Profile

Veru Inc, a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.